Metabolic Solutions is
the leading laboratory in the United States
for medical diagnostic breath tests. Our
CLIA certified clinical laboratory is licensed
to offer laboratory services in all 50 states.
We provide breath test kits and breath sample
analysis to hundreds of physician and medical
professional practices throughout the United
States. Our tests include the Urea Breath
Test to diagnose Helicobacter pylori infection,
and the Hydrogen Breath Test for small intestinal
bacterial overgrowth, lactose intolerance
and fructose malabsorption.
The Urea Breath
Test (BreathTek™)* is a cost
effective, non-invasive, highly accurate
15-minute test to detect Helicobacter Pylori
(H. pylori) infection. The Urea Breath Test
detects active infection, and in contrast
to blood serology tests, doesn't produce
false positives results due to previous
infection. The Urea Breath Test detects
very low levels of H. pylori colonization
and assesses the entire gastric mucosa.
It is ideal for investigation of gut pain,
to confirm the outcome of eradication therapy
and pre-operative screening of bariatric
surgery candidates.
The Small
Intestinal Bacterial Overgrowth Breath Test
is used to detect excessive amounts
of bacteria growing in the small intestines.
Alterations in gastric acid secretion and
intestinal motility provide the setting
for development of bacterial overgrowth.
The consequences of bacterial overgrowth
within the small intestine can be serious
malabsorption resulting in nutritional deficiencies.
In recent literature small intestinal bacterial
overgrowth has been linked with IBS. The
test can be performed in the doctor's office
or given to the patient to do at their convenience
and in their own homes.
The Lactose
Intolerance Breath Test can determine
if gastric distress is being caused by the
inability to digest foods containing lactose.
This test can be performed in a doctor's
office or given to the patient to do at
their convenience and in their own homes.
It provides a safe, non-invasive and cost-effective
solution to diagnose lactose intolerance
with an emphasis on convenience for the
doctor and patient.
The Fructose
Malabsorption Breath Test determines if
a patient has a normal capacity to absorb fructose.
Research shows that fructose malabsorption may
be the cause of common gastrointestinal symptoms
such as bloating, cramps and diarrhea. The breath
test is a patient friendly technique for investigating
this conditions contribution to gastric distress.
The test can be performed in the doctor's office
or given to the patient to do at their convenience
and in their own homes.
The Erythromycin Breath
Test is a quantitative in vivo measure
of hepatic CYP3A4 activity, the most important
drug-metabolizing enzyme present in the liver.
The test provides a phenotypic measurement of
individual variance in hepatic enzymatic activity
due to factors such as disease, diet, concomitant
medications as well as genetic differences.
The Gastric Motility Breath
Test provides an accurate assessment of
solid phase gastric emptying. This test is widely
used by medical/pharmaceutical researchers seeking
an easy, reliable, without radiation, inexpensive
alternative to scintigraphy to assess gastric
motility in clinical studies. In addition, this
breath test technique works well with both human
and animal protocols.
The Methionine Breath
Test measures the degree and progression
of mitochondrial liver impairment in patients
with varied causes of liver disease. The test
is based on the metabolism of 1-13C methionine
(non-radioactive tracer) as a direct measure of
hepatic mitochondrial function.
The Phenylalanine Breath
Test measures hepatic dysfunction. The
Phenylalanine Breath Test is based on the metabolism
of 1-13C phenylalanine (non-radioactive tracer)
as a direct measure of cytolsolic hepatic function.
Researchers interested in the Phenylalanine Breath
Test should contact Metabolic Solutions for additional
information.
|
